Kohlberg Kravis Roberts & Co. L.P. THERAVANCE BIOPHARMA INC Transaction History

Kohlberg Kravis Roberts & Co. L.P.

  • $1.79 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
N/A
-25,525,000 Closed
0 $0
Q1 2020

May 15, 2020
SELL
N/A
-3,440,000 Reduced 11.88%
25,525,000 $249,000
Q4 2019

Feb 14, 2020
BUY
N/A
7,700,000 Added 36.21%
28,965,000 $26.4 Million
Q2 2019

Aug 14, 2019
BUY
N/A
21,265,000 New
21,265,000 $18.3 Million
Track This Portfolio

Track Kohlberg Kravis Roberts & Co. L.P. Portfolio

Follow Kohlberg Kravis Roberts & Co. L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kohlberg Kravis Roberts & Co. L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kohlberg Kravis Roberts & Co. L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email